Type 1 Diabetes Trial, Recruiting (NCT06516614)

Type 1 Diabetes Trial, Recruiting NCT06516614 Sponsor: Vanderbilt University Medical Center Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06516614 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Young people aged 11 to 17 years old at the time of joining the trial
People who have been diagnosed with type 1 diabetes for at least 12 months
People who are not getting enough sleep (less than 8 hours per night for 13–17 year-olds, or less than 9 hours per night for 11–12 year-olds), and who do not have any other sleep disorders or sleep apnea
People whose HbA1c (a measure of blood sugar control over time) is not within the target range of below 7%
People who are able to read and speak English
A caregiver (parent or guardian) who lives with the child at least half of the time and can read and speak English is also required to participate

Who may not be able to join:

People who have other serious health conditions that affect their ability to manage their diabetes
For the optional brain MRI part of the study: people who have metal implants in their body, or who are unable to lie still for up to 60 minutes, may not be able to take part in that portion (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah Jaser, PhD, Vanderbilt University Medical Center

Phone: 615-875-7970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06516614

Sponsor: Vanderbilt University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 615-875-7970

More information: https://clinicaltrials.gov/study/NCT06516614

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Young people aged 11 to 17 years old at the time of joining the trial
People who have been diagnosed with type 1 diabetes for at least 12 months
People who are not getting enough sleep (less than 8 hours per night for 13–17 year-olds, or less than 9 hours per night for 11–12 year-olds), and who do not have any other sleep disorders or sleep apnea
People whose HbA1c (a measure of blood sugar control over time) is not within the target range of below 7%
People who are able to read and speak English
A caregiver (parent or guardian) who lives with the child at least half of the time and can read and speak English is also required to participate

Who may not be able to join:

People who have other serious health conditions that affect their ability to manage their diabetes
For the optional brain MRI part of the study: people who have metal implants in their body, or who are unable to lie still for up to 60 minutes, may not be able to take part in that portion (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vanderbilt University Medical Center

Registry

ClinicalTrials.gov

Start date

18 September 2024

Est. completion

1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sleep Duration; Sleep Variability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov